Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment

NCT01473043 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

DRUG: Axitinib

Sponsor

Pfizer